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Despite the obvious clinical significance of post-stroke angiogenesis in aged subjects, a
detailed transcriptomic analysis of post-stroke angiogenesis has not yet been undertaken
in an aged experimental model. In this study, by combining stroke transcriptomics with
immunohistochemistry in aged rats and post-stroke patients, we sought to identify an
age-specific gene expression pattern that may characterize the angiogenic process after
stroke. We found that both young and old infarcted rats initiated vigorous angiogenesis.
However, the young rats had a higher vascular density by day 14 post-stroke. “New-for-
stroke” genes that were linked to the increased vasculature density in young animals
included Angpt2, Angptl2, Angptl4, Cib1, Ccr2, Col4a2, Cxcl1, Lef1, Hhex, Lamc1, Nid2,
Pcam1, Plod2, Runx3, Scpep1, S100a4, Tgfbi, and Wnt4, which are required for sprouting
angiogenesis, reconstruction of the basal lamina (BL), and the resolution phase. The vast
majority of genes involved in sprouting angiogenesis (Angpt2, Angptl4, Cib1, Col8a1, Nrp1,
Pcam1, Pttg1ip, Rac2, Runx1, Tnp4, Wnt4); reconstruction of a new BL (Col4a2, Lamc1,
Plod2); or tube formation and maturation (Angpt1, Gpc3, Igfbp7, Sparc, Tie2, Tnfsf10), had
however, a delayed upregulation in the aged rats. The angiogenic response in aged rats
was further diminished by the persistent upregulation of “inflammatory” genes (Cxcl12,
Mmp8, Mmp12, Mmp14, Mpeg1, Tnfrsf1a, Tnfrsf1b) and vigorous expression of genes
required for the buildup of the fibrotic scar (Cthrc1, Il6ra, Il13ar1, Il18, Mmp2, Rassf4,
Tgfb1, Tgfbr2, Timp1). Beyond this barrier, angiogenesis in the aged brains was similar to
that in young brains. We also found that the aged human brain is capable of mounting a
vigorous angiogenic response after stroke, which most likely reflects the remaining brain
plasticity of the aged brain.
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INTRODUCTION
Recuperative therapeutic strategies for stroke are focused on revas-
cularization, neuroprotection, and neuroregeneration, but most of
the strategies that have been clinically tested failed to show benefit
in humans. Post-stroke vascular remodeling is an essential event
with crucial importance for neuroregeneration but unfortunately
this process is still incompletely understood and therefore not
exploited for therapeutic purposes (Masuda and Asahara, 2003;
Hayashi et al., 2006; Caiado and Dias, 2012; Liman and Endres,
2012).
Aging is one of the most important risk factors for stroke (Bar-
nett, 2002). Impaired neovascularization was described in elderly,
but the effect of aging on angiogenesis and vascular remodel-
ing after stroke has not been studied in detail. Previous studies
from our group showed that, following insult to the brain, old
rats are still capable of upregulating genes that are active during
development, but the response is often blunted and temporarily
uncoordinated (Buga et al., 2008).
Understanding mechanisms underlying angiogenesis and vas-
cular remodeling after stroke in the elderly is crucial for developing
new treatment strategies to improve the functional outcome after
stroke in aged patients. Unfortunately, the molecular mechanisms
regulating angiogenesis and vascular remodeling in aging brains
are still poorly understood. Endothelial progenitor cells (EPCs) are
likely to promote vasculogenesis after cerebral ischemia. There-
fore, the regenerative potential of EPCs has been under intense
investigation (Peichev et al., 2000). Many angiogenic factors, such
as VEGF, IGFs, or FGFs, are involved in the mobilization of EPCs
and increased levels of EPCs were correlated with increased plasma
VEGF levels in stroke patients (Rafii et al., 2002). However, cur-
rently there is no effective and safe stem cell-based therapy for
stroke (Lees et al., 2012).
Other studies have established that bone marrow-derived EPCs
are present in the systemic circulation, and that they are able to
differentiate into mature endothelial cells (EC) in the ischemic
area, but the number of these cells is reduced by aging (Zhang
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et al., 2006; Mikirova et al., 2009). Previously, we have shown that
cytokine-induced generation of bone marrow-derived EPCs can
be enhanced by the administration of granulocyte-colony stimu-
lating factor (G-CSF), and leads to improved functional outcome
after stroke in aged rats (Popa-Wagner et al., 2010).
Few studies have investigated human post-stroke angiogenesis
at the molecular level. Thus, Krupinski et al. (1994) noted active
angiogenesis in the penumbral areas of patients who survived from
several days to weeks after cerebral stroke, as well as a positive
correlation between microvessel density and patient survival. In
subsequent studies, the authors demonstrated an increased syn-
thesis of angiogenic growth factors such as FGF-2, platelet-derived
growth factor (PDGF), VEGF, and their receptors within hours of
stroke that correlated with blood vessel growth in the penumbra
(Krupinski et al., 1996, 1997).
The literature on gene expression profiles after stroke in
humans also is limited. In this regard, Vikman and Edvinsson
(2006) have shown similarities in gene expression profiles between
human strokes and those in animal models, and reported new
genes that support the dynamic changes that occur in the mid-
dle cerebral artery branches supplying the ischemic region. Also,
promising results of blood genomic profiling in human stroke
have been obtained in pilot studies (Moore et al., 2005; Tang et al.,
2006; Tan et al., 2009). These results argue for the utility of pro-
angiogenic therapies in stroke,given the potential effects consisting
of increasing blood flow, decreasing infarct size, and support-
ing the restoration and recovery of neurovascular networks after
ischemia (Liman and Endres, 2012).
Despite the obvious clinical significance of post-stroke angio-
genesis in aged subjects, a detailed analysis of transcriptomics
of post-stroke angiogenesis has not been done yet in an aged
experimental model. By combining stroke transcriptomics with
immunohistochemistry in aged rats and post-stroke patients, in
this study we aimed at (i) identifying an age-specific gene expres-
sion pattern that may characterize the angiogenic process after
stroke, (ii) exploring the potential of older animals to initiate
regenerative processes following cerebral ischemia by supportive
angiogenesis. This approach should allow us to identify new thera-
peutic targets that are crucial for enhancing neurorestoration after
stroke in the elderly.
MATERIALS AND METHODS
ANIMALS
Thirty young (3–4 months of age) and 45 aged (19–20 months)
male Sprague-Dawley rats, bred in-house, were used for the tran-
scriptome analysis. The two age groups were divided randomly
into 3- and 14-day post-stroke survival groups. In addition, 19
young (3–5 months of age) and 24 aged (18–20 months) male
Sprague-Dawley rats were used as controls. Further 10 young and
15 aged post-stroke rats were used for the histological analysis.
Body weights ranged from 290 to 360 g for the young rats and from
520 to 600 g for the aged rats. The group sizes for the aged rats were
larger to compensate for the higher post-ischemic mortality rate
(20%) as compared to young animals (12%) (Popa-Wagner et al.,
1999, 2010). The rats were kept in standard cages in a tempera-
ture (22°C), humidity (40–60%), and light period (07.00–19.00 h)
controlled environment and had free access to food and water.
All experiments were approved by the University Animal Experi-
mentation Ethics Board as meeting the ethical requirements of the
German National Act on the Use of Experimental Animals.
REVERSIBLE OCCLUSION OF THE MIDDLE CEREBRAL ARTERY
Cerebral infarction was induced by transcranial interruption of
blood flow by transiently lifting the middle cerebral artery with a
tungsten hook as previously described (Popa-Wagner et al., 1999).
Eighteen hours prior to surgery, rats were deprived of food to min-
imize variability in ischemic damage that can result from varying
plasma glucose levels. Water remained available at all times. The
right middle cerebral artery (MCAO) was lifted with a tungsten
hook attached to a micromanipulator (Maerzhaeuser Precision
Micro-manipulator Systems, Fine Science Tools). Both common
carotid arteries were then occluded by tightening pre-positioned
thread loops for 90 min. Throughout surgery, anesthesia was
maintained by spontaneous inhalation of 1–1.5% halothane in a
mixture of 75% nitrous oxide and 25% oxygen. Body temperature
was controlled at 37°C by a Homeothermic Blanket System (Har-
vard Apparatus). The local changes in blood flow were monitored
using a laser Doppler device (Perimed, Stockholm, Sweden), and
blood gases were measured at several time points during ischemia.
A decrease in the laser Doppler signal to <20% of control val-
ues was considered to indicate successful MCA occlusion. After
90 min, the common carotid arteries were re-opened. Surgery was
performed under antiseptic conditions to minimize the risk of
infection. Subsequent to survival times of 3 or 14 days, rats were
deeply anesthetized with 2.5% halothane, 75% nitrous oxide, and
25% oxygen, and the blood removed by perfusion with neutral
buffered saline. Brains were cut into 2 mm slices and the peri-
infarcted area was microdissected under a microscope and stored
at−70°C until use.
RNA EXTRACTION AND RNA QUALITY CONTROL
After the tissue was homogenized, total RNA was extracted from
microdissected tissue using TRIzol reagent (Invitrogen Life Tech-
nologies, Karlsruhe, Germany). Genomic DNA was removed using
the RNeasy Plus kit (Qiagen).
MICROARRAY HYBRIDIZATION
The hybridization experiments were repeated two times on dif-
ferent occasions. Prior to sample preprocessing, RNA integrity
of RNA pools was assessed with the RNA 6000 nano kit using
the Bioanalyzer 2100 instrument (Agilent, Böblingen, Germany).
RNA integrity numbers ranged between 6.5 and 8.2. Two hun-
dred nanograms of each sample were processed with the whole
transcript (WT) expression kit (Ambion, Darmstadt, Germany),
i.e., subjected to RNA amplification via reverse transcription to
double-stranded cDNA and subsequent in vitro transcription; this
was followed by another round of reverse transcription yielding
single-stranded DNA in sense orientation. Hybridization cock-
tails were produced after fragmentation and biotin labeling of
target DNAs following the protocol of the GeneChip WT termi-
nal labeling kit (Affymetrix, Santa Clara, CA, USA). Microarray
hybridization to GeneChip Rat Gene 1.0 ST arrays (Affymetrix)
was performed according to the manufacturer’s protocol using
the Fluidics Station 450 with the program FS450_0007. CEL files
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from scanned microarrays were produced with the expression con-
sole (Affymetrix). Each array reflected the expression of 19–24
pooled animal samples. Since gene expression variance is notori-
ous in aged animals, pooling of RNA from a large group of aged
animals drastically reduces gene expression variance that is oth-
erwise observed between individually hybridized animal samples.
However, pooled design does not allow estimating within sam-
ples variation, which is one of the major limitations of our study.
Nevertheless, the identification of differentially expressed genes is
not adversely affected by pooling, and pooling has been recom-
mended when fewer than three arrays are used in each condition
(Kendziorski et al., 2005).
MICROARRAY EVALUATION
Consistently high quality microarray data was ensured by visual
inspection of scanned images for hybridization artifacts and corre-
spondence analysis (COA) of raw and normalized microarray data.
Normalizations were performed with the Quantiles method (Bol-
stad et al., 2003); background correction and probe set summary
were achieved with robust microarray average (RMA) (Irizarry
et al., 2003). Differentially expressed genes were determined by
comparing 3 days post-stroke vs. naive and 14 days post-stroke
vs. naïve. These comparisons were done separately for young
and aged animals. The false discovery rate (FDR) of differen-
tial expression for the described comparisons was estimated with
an empirical Bayes methodology employing lognormal normal
data modeling (Kendziorski et al., 2003) as previously described
(Buga et al., 2012). Results were confined to probe sets belong-
ing to gene ontologies (GO) related to angio- and vasculo-
genesis comprising GOs “angiogenesis” (GO:0001525), “vascu-
logenesis” (GO:0001570), “positive regulation of angiogenesis”
(GO:0045766),“positive regulation of smooth muscle cell prolifer-
ation”(GO:0048661), and“blood vessel endothelial cell migration”
(GO:0043534), which resulted in a total of 292 non-redundant
probe sets. Expression values thereof were subjected to agglom-
erative hierarchical clustering and results were displayed as a heat
map. The effect of stroke, post-stroke time, and age of rats was
quantified by the Eigenvalues determined from a COA with 292
angio- and vasculogenesis probe sets. In brief, COA is an ordi-
nation method that performs its ordination simultaneously on
column (sample) and row (probe set) scores such that dependen-
cies between data points become evident. The COA visualization
shows samples and probe sets in the same coordinate system, typ-
ically made up of the two most informative axes describing inde-
pendent variation in the dataset. Due to the unsupervised nature
of the COA, there is no predefined axis notation. All analyses were
performed in R version 2.14.01 along with Bioconductor2 pack-
ages affy (for data import and preprocessing), made4 (for COA and
heatmap), and EBarrays (for detection of differential expression).
QUANTITATIVE REAL-TIME PCR
All described genes were checked by RT-PCR. For quantitative
real-time PCR (qPCR), we synthesized cDNA from large pools
(n= 19–24) of total RNA with the high-capacity cDNA reverse
1www.r-project.org
2www.bioconductor.org
transcription kit (Applied Biosystems, USA). The qPCR was per-
formed in 96-well 0.1-ml thin-wall PCR plates (Applied Biosys-
tems) in the Step One Plus System (Applied Biosystems). Each
20µl reaction contained 10µl iQ SYBR Green Master Mix (Bio-
Rad Laboratories, Hercules, CA, USA), 2µl gene-specific forward
and reverse primer mix (Qiagen, Alameda, CA, USA), and 8µl
pre-diluted cDNA. No template controls contained nuclease-free
water instead. The cycling conditions were 3 min 95°C to activate
iTaq DNA polymerase followed by 45 cycles with 30 s denatura-
tion at 95°C, 30 s annealing at 58°C, and 30 s elongation at 72°C.
At the end of the amplification cycles, melting curves were used
to validate PCR product specificity. All samples were amplified in
triplicate. Data were analyzed using the∆∆Ct method (Livak and
Schmittgen, 2001). The expression levels of genes of interest were
normalized to the average of expression level of the two house-
keeping genes (hypoxanthine guanine phosphoribosyltransferase
1, HPRT1 and ribosomal protein 19, RPL 19) from the same sam-
ple. So the relative expression for a gene of interest was defined
as the ratio of expression of the gene to that of the housekeep-
ing gene. The fold change for a gene of interest was defined as
the ratio of the relative expression in the ipsilateral hemisphere
(stroke lesioned, peri-infarcted or PI) to that in the naive animals.
Eurofinn, Germany provided all primers.
DETERMINATION OF THE INFARCT VOLUME
To assess the size of the infarct induced by transient focal ischemia,
every 10th section was stained with NeuN, a marker of neuronal
nuclei. In previous studies, we have found that the disappearance
of NeuN is a reliable indicator of neuronal degeneration and death
(Badan et al., 2003). Images of the stained sections were taken to
cover the entire infarcted area, which was then calculated as the
sum of partial areas using Image J analysis software. Integration of
the resulting partial volumes gave the total volume of the ipsilat-
eral hemisphere along with the total volume of the cortical infarct;
lesion volume was then expressed as percent of the hemispheric
volume.
IMMUNOHISTOCHEMISTRY OF RAT TISSUE
Sections (25µm-thick) were cut on a freezing microtome and
processed for immunohistochemistry as previously described
(Popa-Wagner et al., 2007a). Briefly, after incubation with block-
ing solutions containing 3% donkey serum/10 mmol/L PBS/0.3%
Tween 20, tissue sections were exposed overnight at 4°C either to
mouse anti-NeuN (1:1000, Millipore, Germany) or mouse anti-rat
CD31 (1:1000,AbD Serotec, Duesseldorf, Germany) diluted in PBS
containing 3% normal donkey serum and 0.3% Tween 20. After
washing in PBS containing 0.3% Tween, the signal was ampli-
fied utilizing an anti-mouse polymer-based secondary detection
system (Histofine polymer-HRP, Nichirei, Japan) diluted 1:10 in
PBS containing 1% normal goat serum and 0.3% Tween 20. After
washing in PBS, sections were stained with tyramide–FITC.
For phenotyping, sections were incubated first with rabbit anti-
laminin 5 (1:2000, Sigma, Munich, Germany) followed by mouse
anti-P4HB monoclonal antibody (Novus Biological, UK). Cells
and blood vessels were visualized by adding Cy3-conjugated don-
key anti-rabbit IgG (H+ L) (1:4000) or Cy2-conjugated donkey
anti-mouse IgG (H+ L) (1:3000).
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For BrdU detection, free-floating sections were incubated in
2 M HCl at 37°C for 30 min, and rinsed in 0.1 M borate buffer
(pH 8.5) at room temperature for 10 min. After neutralization,
sections were incubated in blocking solution containing 10% goat
serum, 0.3% Triton X-100, 0.2% gelatin in PBS overnight at 4°C,
followed by rat anti-BrdU antibody (1:2000, Serotec, UK) at 4°C
for 48 h. BrdU-positive cells were visualized by incubating with
Cy5-conjugated donkey anti-rat IgG (H+ L) (1:3000).
IMMUNOHISTOCHEMISTRY IN HUMAN SUBJECTS
To analyze angiogenesis after ischemic stroke, formalin-fixed,
paraffin-embedded archived brain tissue blocks containing both
lesional and peri-lesional areas were selected from 15 stroke
patients with a survival post-stroke time ranging from 12 h to
7 days. Two normal subjects were used as controls. Immediately
after death, the bodies were refrigerated according to standard
procedures and tissue samples were processed within 4–8 h from
death. Death was attributed to complications such as massive
edema and brain herniation with rostrocaudal deterioration, or
cardiovascular arrhythmias. Written informed consent to autopsy
was obtained for each patient from the relatives or their caregivers.
Demographic data of patients and controls are given in Table 1.
A sequential methodology was utilized for NeuN/CD105
immunostaining. Briefly, after antigen retrieval, sections were
incubated for 30 min in 1% hydrogen peroxide. After a block-
ing step of 1 h in 3% skim milk, the slides were incubated with
the mouse anti-NeuN antibody (1:100; Millipore, Darmstadt,
Germany) overnight at 4°C in a humidified chamber. The next
day, the signal was amplified for 30 min utilizing an anti-mouse
polymer-based secondary detection system (Nichirei-Histofine,
Japan), and detected with DAB (Dako, Hamburg, Germany). In
the second round of immunolabeling, the slides were incubated
overnight with rabbit anti-CD105 antibody (1:100; LifeSpan Bio-
sciences, USA). The next day, the antibody was amplified with
a goat anti-rabbit biotinylated secondary antibody (Dako, Ham-
burg, Germany) together with AP-labeled streptavidin (ABC kit,
Dako, Hamburg, Germany). The second signal was detected using
Fast Red. After hematoxylin staining, the slides were coverslipped
in a glycerol-based medium.
QUANTITATION OF MICROVASCULAR DENSITY
Microvascular density was quantitated using the “hot spot” analy-
sis covering 30% of the infarcted area. Briefly, hot-spots, i.e.,
regions with a high density of CD105-positive microvessels in
humans and CD31-capillaries in rats, were identified using a 40×
objective and were then counted using 20× objective, correspond-
ing to a microscopic field of 0.7386 mm2. Counting was done
by two independent observers and the results are expressed as
means± SD.
MICROSCOPY
For light microscopy, a Nikon Eclipse (Nikon, Duesseldorf, Ger-
many) was used. Confocal microscopy images were acquired using
a Zeiss LSM710 laser-scanning confocal system with spectral
detection capabilities, and Zen 2010 software version 6.0 (Carl
Zeiss Microscopy GmbH, Jena, Germany) was used for image
acquisition and analysis. Excitation light was provided by 488,
Table 1 | Case demographics of ischemic stroke patients and controls.
Patient Age Sex Survival time
1 78 F 6 days
2 51 F 36 h
3 68 M 12 h
4 67 M 40 h
5 51 F 36 h
6 NA M 20 h
7 66 M 30 h
8 77 F 7 days
9 68 F 2 days
10 82 M 12 h
11 77 F 5 days
12 64 F 28 h
13 74 M 12 h
14 65 M 2 days
15 83 F –
16 68 M Control
17 85 M Control
543, and 634 nm laser lines; fluorescence emission was detected at
500–530 nm for FITC (green), 550–600 nm for Rhodamine (red),
and 650–710 nm for Cy5 (blue) in separate tracks, using a confo-
cal aperture of 1 Airy unit. Some of the images were acquired as
z-stacks and 3D reconstruction was performed using a software
algorithm (maximal projection).
ENZYME-LINKED IMMUNOSORBENT ASSAY MEASUREMENT OF CD31
CD31 was measured via ELISA using homogenates from the per-
infarcted area. Briefly, dissected tissue from the peri-infarction
area, the corresponding contralateral area, and the sham control
was homogenized in TRIzol reagent (Invitrogen, Germany). Sam-
ple preparation was performed according to the manufacturer’s
protocol. Finally, the vacuum-dried protein pellet was dissolved
in sample buffer containing 8 M urea, 2 M thiourea, 4% CHAPS,
65 mM DTT, and 40 mM Tris. Protein amounts were quanti-
fied by BCA protein assay (Pierce). ELISA plates (Santa Cruz,
Heidelberg, Germany) were coated with 2µg protein/well in coat-
ing buffer (1% deoxycholate, 10 mM sodium carbonate, 30 mM
sodium bicarbonate, and 0.05% NaN3, pH 9.6) overnight at room
temperature. The plate was washed three times with 1× PBS with
0.05% Tween 20 and incubated with blocking buffer (2% BSA in
1× PBS with 0.05% Tween 20) for 2 h at room temperature. For a
negative control, wells were incubated with blocking buffer. Two
replicate wells were prepared under each condition. After washing,
the wells were incubated with a polyclonal mouse anti-CD31 (AbD
Serotec, Duesseldorf) or rabbit anti-GAPDH antibody (New Eng-
land Biolabs, Frankfurt) for 2 h, followed by washing and binding
of secondary HRP-conjugated polymer (Histofine-HRP, Nichirei,
Japan) for 2 h. The plate was washed three times, and then 100µL
of a 3,3′,5,5′-tetramethylbenzidine (TMB) substrate solution was
added to each well. The plate was incubated at room temperature
for 15–30 min and absorbance was measured at 450 nm with a
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universal microplate reader. Calibration was done using known
amounts of CD31 standard.
DOT BLOT ANALYSIS OF CD31
CD31 was measured via a modified chemiluminescent ELISA
using homogenates from the per-infarcted area. Two micro-
grams of protein were applied to a PVDF membrane using a
vacuum dot blot apparatus (Hoeffer Scientific). From this step
on, the procedures were performed in the well, much like an
ELISA assay (i.e., without dismantling the dot blot apparatus).
The wells were incubated with blocking buffer containing 2%
BSA in TBS for 1 h at room temperature while being gently
shaken. After washing, the wells were incubated with a polyclonal
mouse anti-CD31 (AbD Serotec, Duesseldorf) or rabbit anti-
GAPDH antibody (New England Biolabs, Frankfurt) for 2 h, fol-
lowed by washing and binding of secondary alkaline phosphatase-
conjugated polymer (Histofine-HRP, Nichirei, Japan) for 2 h.
Finally the antigen–antibody complex was visualized by exposing
the chemo-luminescent signal to X-ray film.
STATISTICAL ANALYSIS
The main effects of age, time, and manipulation (stroke vs. sham),
as well as interactions, for the infarct volume,ELISA measurements
and microvascular density in animal models were evaluated by
ANOVA followed by Tukey post hoc analyses using SPSS software
(SPSS Inc., Chicago, IL, USA). The level of significance was set at
p≤ 0.05, two-tailed test. For human samples, data were analyzed
by using Student’s t -test. A p value of <0.05 was considered to be
statistically significant. The relationship between metric data and
histological data was assessed using Pearson’s product moment
correlation (Pearson’s r).
RESULTS
The dendrogram showed that relative expression values clearly
distinguished naïve rats from their post-stroke littermates
(Figure 1A). Within the group of infarcted rats, samples clustered
according to the time following experimentally induced MCA
occlusion. The left-hand dendrogram subdivided expression levels
into two major groups; the larger one consisted of those probe sets
whose expression was generally higher in post-stroke animals than
in naïve ones, whereas the smaller group contained transcript clus-
ters with reduced expression. In addition to these major groups,
there was a group with a less consistent pattern of expression, i.e.,
those genes were weakly expressed in untreated animals, strongly
expressed at 3 days after stroke, and then downregulated at 14 days.
Finally, closer inspection of the heat map revealed that the age of
rats also influenced gene expression levels, i.e., at day 3 the pattern
of expression was similar in the two age groups but then became
very dissimilar by day 14 post-stroke. For further examination
of data, we performed a COA for those genes that were differ-
entially expressed. By this method, we concluded that the major
difference in gene expression between naive and post-stroke sam-
ples was caused by lesioning (effect of stroke), which accounted
for 75% of the information content. Further, the post-stroke time
accounted for 15% of the information content while age accounted
for a surprisingly small proportion, <10% (Figure 1B). Further,
in Figure 1C, we can nevertheless distinguish the age effect shown
by the green circle for young and the red circle for aged animals.
The effect of lesioning is here given as Axis 1, and the effect of the
post-stroke time as Axis 2.
AGE-SPECIFIC REGULATION OF GENE EXPRESSION AFTER STROKE
(VENN DIAGRAMS)
Of the 292 angio- and vasculogenesis probe sets, 59 were found
to be differentially expressed in at least one of the comparison
(Figure 1D). At day 3 post-stroke, 17 probe sets displayed an
age-specific expression, thereof 10 in young and 7 in aged rats
(Figure 1D); 28 probe sets are differentially expressed in both age
groups. By day 14 after stroke, a total of 10 probe sets displayed
an age-specific expression, 4 in the young group and 6 in the aged
group, while 32 probe sets were shared by both age groups. The
genes showing an age-specific expression are presented in detail
below (Table 2).
PERSISTENT UPREGULATION OF MATRIX PROTEASES AND
INFLAMMATORY MEDIATORS IN THE BRAINS OF AGED RATS
Genes that were new for stroke or showed an age-dependent
expression were further verified by RT-PCR (Table 2). An early
event after an ischemic insult is the activation of microglia in the
peri-infarcted area, especially in aged rats (Popa-Wagner et al.,
2007a).
Activated microglia and macrophages release the pro-
inflammatory cytokine tumor necrosis factor alpha (TNF alpha)
into the infarct area, which induces a number of pro-inflammatory
changes; these in turn increase leukocyte adhesion, transendothe-
lial migration, and vascular leakage and edema formation
(Bradley, 2008). TNF-alpha is synthesized as a trimeric type II
transmembrane precursor, which is then converted to a soluble
form by the sheddase activity of ADAM17 (TACE-tumor necrosis
factor alpha converting enzyme) a membrane-anchored metallo-
proteinase on EC and pericytes that was upregulated in both age
groups, with higher expression in aged brains (twofold vs. young
brains). Adam 17 then stimulates Notch signaling and TNF-alpha
expression, two potent promoters of angiogenesis (Gridley, 2007;
Bradley, 2008; Chen et al., 2009). ADAM17 is further responsible
for the proteolytic release of the vascular endothelial growth factor
(VEGF) receptor 2 (VEGF2) (Swendeman et al., 2008; Weskamp
et al., 2010).
TNF alpha is also a potent inducer of angiogenesis via VEGF,
and two genes of the TNF family,Tnfrs1a and Tnfrs1b, were belat-
edly upregulated (twofold over the levels shown by the young
animals) in the lesioned area of aged rats. Of these,Tnfrs1b has not
been previously described in post-stroke angiogenesis. The pro-
inflammatory TNF alpha also caused a twofold higher induction
of the cytokine Cxcl12 mRNA by day 14 in the brains of aged vs.
young rats.
Disruption of EC contact and their detachment from the
basal lamina (BL) are caused by the family of matrix metallo-
proteases (MMPs) during the tissue remodeling process (Sabeh
et al., 2009; Liu et al., 2010). A new player in inflammation-
induced vascular remodeling is collagenase Mmp8, which is pro-
duced by macrophages, and which is abundantly expressed in the
infarcted area. Of note was the persistent upregulation of the
Mmp12 gene encoding a metalloelastase and Mmp14 encoding
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FIGURE 1 | (A) Heatmap of genes differentially expressed between
post-stroke and naïve animals. Scaled expression values of all 292
differentially expressed genes are shown for each group with deep blue being
the lowest and dark red the highest expression level. The depicted
dendrograms cluster samples (top) and genes (left) employing average
agglomeration and Euclidian distance measure. Cluster branch stability was
tested with the R-package “pvclust”. Approximately unbiased p-values
calculated by multiscale bootstrap resampling are shown at cluster branches.
(B) Correspondence analysis of differentially expressed genes and samples
grouped by animal age. The panel depicts the Eigenvalues of the
correspondence analysis and shows that the major factors contributing to the
variance of stroketomics analysis were stroke (75%), post-stroke time (15%),
and age (10%). (C) Sources of variability were stroke and post-stroke time,
which formed the coordinates. The graph shows the distribution of transcripts
(black dotes) as a function of treatment (stroke) and post-stroke time.
Samples from young (green ellipse) and aged (red ellipse) animals show an
extensive overlap as well as some difference in their post-stroke response.
(D) Venn diagrams for 3 and 14 days post-stroke penumbra (PN) showing
genes that were up- or downregulated exclusively in old or young rats, or in
both age groups.
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Table 2 | New or age-related angiogenesis and vascular remodeling-related genes after stroke verified by RT-PCR.
Sequence
code
Gene
symbol
Function Young
3 days
Young
14 days
EP Aged
3 days
Aged
14 days
EP
FC SD FC SD FC SD FC SD
INFLAMMATION-INDUCED VASCULAR REMODELING
10872361 Bai2 De novo angiogenesis inhibitor −2.9 0.23 1.33 0.01 −2.70 0.14 −1.34 0.11
10736697 Ccl2* EC; monocyte chemoattractant protein; angiogenic 23.3 1.56 5.72 0.5 D 20.9 0.56 7.72 0.33 D
10771655 Cxcl10 Leukocyte recruitment via Tnfa signaling 2.90 0.51 6.36 0.43 D 3.65 0.09 9.00 1.1 D
10858165 Cxcl12 Chemoattractant, EPCs and SMC; promotes angiogenesis 2.07 0.21 3.06 0.17 A 2.81 0.15 6.15 0.35 A
10767373 Cxcr4 Chemoattractant EPC; promotes angiogenesis 13.7 0,22 3.81 0.54 D 9.37 0.33 4.68 0.28 D
10908896 Ets1* TF, early stage; neovascularization 4.3 0.05 2.33 0.22 D 6.10 1.14 2.72 0.29 D
10907913 Mmp8 Macrophage collagenase; BM remodeling via Tnfa 6.3 0.1 3.34 0.09 D 4.34 0.14 8.01 0.34 A
10907869 Mmp12* Fibroblasts collagenase (COL1) 12.3 0.23 3.54 0.1 B 14.0 0.45 7.59 0.33 D
10780205 Mmp14* Collagenase; BL remodeling 4.7 0.46 5.07 0.70 A 7.72 0,90 11.2 0,59 A
10714103 Mpeg1 Inflammatory mediator; macrophages 4.6 0.31 4.15 0.34 A 3.90 0.22 9.14 0.44 C
10858967 Tnfrsf1a Inflammatory mediator; apoptosis 3.2 0.02 3.33 0.04 A 3.78 0.17 6.29 0.07 A
10881424 Tnfrsf1b Attenuates inflammation 4.6 0.25 4.16 0.20 A 4.41 0.14 8.28 0.10 A
SPROUTING ANGIOGENESIS
10789291 Angpt2 Promotes the dissociation of pericytes 8.2 0.48 3.55 0.19 D 4.37 0.48 7.17 0.27 A
10835654 Angptl2 Macrophages; pro-angiogenic 4,3 0.21 3.32 0.15 A 2.44 0.11 3.99 0.2 A
10901166 Angptl4 EC; pro-angiogenic 4.5 0.2 1.90 0.24 B 2.48 0.4 8.51 0.02 A
10723032 Cib1* Modulator of EC proliferation and migration 7.8 0.78 1.69 0.09 B 3.46 0.14 8.01 0.00 A
10750685 Col8a1 VSMC; fibroblasts and SMC proliferation via Tgfb 16.3 0.26 1.60 0.2 B 12.70 1.58 8.05 0.88 D
10914614 Ccr2* Chemoattractant EPC; promotes angiogenesis 4.1 0.19 1.49 0.07 B 2.28 0.09 2.48 0.11 A
10775900 Cxcl1 Chemoattractant EPC; promotes angiogenesis 95. 6.77 8.25 1.97 D 22.0 4.16 19.1 1.15 A
10940663 Eng** EC; pro-angiogenic via TGFb signaling 5.6 0.19 1.84 0.15 B 3.24 0.14 6.20 0.14 A
10715100 Hhex** TF; promotes vasculogenesis via VEGF 6.1 0.32 2.29 0.26 D 4.29 0.27 3.12 0.07 D
10907689 Itga5 BV stabilization 3.6 0.22 1.60 0.06 B 2.88 0.11 1.90 0.09 B
10819052 Lef1 EC proliferation and migration 4.1 0.49 1.60 0.13 B 2.19 0.06 2.38 0.05 A
10808959 Nrp1 2.5 0.48 1.33 0.22 NC 2.81 0.26 5.72 1.02 A
10940659 Pecam1 EC marker; angiogenesis 5.5 0.48 1.65 0.08 B 2.89 0.18 3.38 0.21 A
10832299 Pttg1ip EC proliferation and migration 6.4 0.45 2.59 0.27 D 4.28 0.25 2.90 0.11 D
10905316 Rac2 EPC polarity and proliferation 5.2 0.11 3.25 0.11 A 5.27 0.31 7.80 0.26 A
10753222 Runx1 EPC; pro-angiogenic 3.3 0.21 2.30 0.17 A 2.15 0.44 4.63 0.2 A
10758645 Sh2b3 EC adhesion and migration 4.0 0.32 2.23 0.16 A 3.78 0.28 2.65 0.5 A
10781022 Sox7 TF; arterial development; pro-angiogenic 4.9 0.77 1.64 0.23 B 5.97 0.95 1.36 0.28 B
10797726 Tpm3 EC migration 3.6 0.23 2.44 0.15 A 3.24 0.19 3.19 0.3 A
10790712 Tpm4 EC migration 3.7 0.21 1.12 0.07 B 3.74 0.22 3.38 0.09 A
10751048 Tagln VSMC proliferation and differentiation 10.8 0.58 1.82 0.23 B 21.1 0.49 2.21 0.17 B
10873021 Wnt4 VSMC proliferation and migration 2.29 0.05 2.70 0.19 A 1.10 0.01 6.20 0.14 C
RECONSTRUCTION OF BASAL LAMINA
10889339 Adam17 EC; ECM and vascular remodeling via Tnfa and Il6ra 2.66 0.2 1.83 0.1 B 4.45 0.3 2.70 0.5 A
10792997 Col4a2** Reconstruction of a new BM 23 1.34 1.49 0.01 B 5.36 0.5 3.41 0.01 A
10929766 Col6a3 Reconstruction of a new BM 21.5 2.71 18.34 3.11 A 24.3 1.24 22.0 6.2 A
10928761 Fn1 BV stabilization 4.5 0.23 2.39 0.2 A 3.32 0.3 3.69 0.45 A
10768668 Lamc1 Reconstruction of a new BM 4.6 0.09 1.77 0.13 B 1.57 0.14 4.27 0.02 C
10782387 Nid2 Reconstruction of a new BM 3.6 0.29 2.20 0.63 A 1.57 0.32 2.77 0.91 C
10912255 Plod2** Fibroblasts; collagen maturation; BM maturation 3.8 0.22 1.80 0.05 B 1.57 0.03 3.66 0.08 C
10757461 Plod3 Reconstruction of a new BM via COL4 and COL6 2.0 0.20 2.29 0.12 A 2.80 0.11 1.65 0.01 B
TUBE FORMATION AND BV MATURATION
10903529 Angpt1 PVC; BV maturation/stabilization 2.7 0.51 3.78 0.61 A 2.48 0.4 8.51 0.61 A
10853559 Col1a2 Adventitial fibroblasts; aneurysms 2.2 0.09 3.9 0.09 A 1.59 0.13 4.32 0.10 C
(Continued)
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Table 2 | Continued
Sequence
code
Gene
symbol
Function Young
3 days
Young
14 days
EP Aged
3 days
Aged
14 days
EP
FC SD FC SD FC SD FC SD
10891780 Fbln5 EC; vascular remodeling; BV elasticity 10.7 1.5 2.03 0.03 D 8.66 0.5 2.60 0.15 D
10702913 Fndc1 BV stabilization 1.34 0.15 3.94 0.17 C 1.13 0.09 3.91 0.11 C
10939764 Gpc3* Co-receptor for Fgf9; vascular development 1.74 0.00 3.18 0.49 A 5.38 0.64 6.16 0.62 A
10772169 Igfbp7 Vascular remodeling; lumen formation 1.79 0.13 2.84 0.10 C 1.49 0.06 4.37 0.45 C
10739721 Itgb4 Vascular integrity; BV maturation 3.65 0.1 2.97 0.28 A 2.74 0.55 2.96 0.3 A
10817711 Notch2 Pro-angiogenic via VEGFR2 1.7 0.10 2.30 0.02 C 1.36 0.12 2.45 0.08 C
10760971 Pcolce Fibroblasts; vascular remodeling; lumen formation 1.34 0.2 3.84 0.1 C 1.52 0.3 5.78 0.31 C
10802040 Pdgfrb Pericytes; BV stabilization 2.24 0.04 2.26 0.06 A 1.68 0.10 2.95 0.10 C
10753222 Runx3 Negative regulator of EPC 9.82 0.5 10.58 0.2 A 4.28 0.1 1.32 0.1 B
10746139 Scpep1 SMCs; elastogenesis and BV maturation 7.78 0.01 7.04 0.61 A 8.17 0.62 6.09 0.27 A
10817057 S100a4 SMC proliferation and migration; aneurysms 16.2 2.3 17.49 2.02 A 9.78 1.2 8.16 1.03 A
10742802 SPARC** Pericytes recruitment; BV stabilization 1.97 0.12 4.84 0.51 C 2.49 0.13 8.42 0.55 C
10879278 Tie1 EC; modulates Angpt1/Tie2 signaling 2.52 0.05 1.69 0.11 B 2.10 0.06 1.67 0.09 B
10869946 Tie2 Sprouting angiogenesis via Angpt2 8.23 0.48 3.55 0.19 D 4.17 0.48 7.17 0.27 A
10814528 Tnfsf10 EC; pro-apoptotic 1.80 0.20 2.37 0.16 C −1.15 0.40 9.01 0.22 C
Vegfc 1.05 0.13 2.99 0.2 C 1.66 0.23 1.14 0.11 NC
10921772 Vegfa** Sprouting angiogenesi and tube formation 1.15 0.09 2.40 0.07 C 1.34 0.22 1.09 0.05 NC
BUILDUP OF FIBROTICTISSUE
10737532 Col1a1 Fibrotic scar via Tgfb; aneurysm 6.7 0.65 16.88 0.78 C 10.5 1.41 45.4 1.06 C
10923052 Col3a1 Adventitial fibroblasts; aneurysms 16.0 0.91 57.82 0.32 C 32.8 2.44 237 7.44 C
10896263 Cthrc1* Fibroblasts and SMC; fibrosis via Tgfb 13.0 1.47 1.80 0.02 B 11.4 0.22 10.8 1.46 A
10824530 Il6ra* Promotes vascular leakage 1.90 0.15 1.90 0.60 NC 1.58 0.66 3.55 0.52 C
10813007 Il6st Promotes vascular leakage 1.73 0.08 2.91 0.11 C 1.43 0.12 3.34 0.23 C
10754983 Il13ra1 Inhibits MMP secretion by fibroblasts; fibrosis 3.76 0.17 3.14 0.12 A 3.3 0.20 6.73 0.21 A
10909874 Il18 Microglia; pro-fibrotic via fibroblasts proliferation 4.17 0.24 1.77 0.04 B 3.66 0.22 7.59 0.44 C
10809540 Mmp2 Fibroblasts to myofibroblasts conversion 2.88 0.32 2.7 0.62 A 5.08 1.02 14.5 6.41 A
10749663 P4hb Fibroblasts; collagen synthesis; fibrosis 2.34 0.29 2.08 0.07 A 2.39 0.66 2.84 0.19 A
10776459 Pdgfra Fibrosis via TNFalpha and TGFbeta 1.74 0.05 2.06 0.03 C 1.38 0.02 3.15 0.03 C
10864874 Rassf4 Mesenchymal cells; fibrosis 6.25 0.1 12.24 1.46 A 4.73 0.86 23.3 2.9 C
10927842 Stat1 Promotes vascular leakage via Il6r 2.01 0.01 2.55 0.02 A 1.57 0.05 3.53 0.09 C
10893067 Stat2 Promotes vascular leakage via Il6r 1.59 0.04 1.67 0.06 NC 1.37 0.02 2.48 0.12 C
10868923 Tgfbr1 Fibroblasts and SMA proliferation; fibrosis 8.29 1.11 14.15 0.66 A 9.39 0.81 12.1 0.09 A
10920745 Tgfbr2* Fibroblasts, SMC proliferation; fibrosis 5.06 0.44 3.80 0.40 A 6.87 0.71 10.1 0.46 A
10705213 Tgfb1 Fibroblasts and SMA proliferation; fibrosis 6.64 0.78 16.57 0.81 C 5.97 0.36 58.8 0.78 C
10797138 Tgfbi Fibroblasts and SMA proliferation; inhibition 3.30 0.21 1.41 0.08 B 1.27 0.12 1.57 0.13 NC
10865094 Wnt5b EC proliferation and migration 1.39 0.13 3.29 0.28 C 3.13 1.27 5.10 0.73 A
10936482 Timp1 Inhibits MMPs 40.6 2.34 8.53 1.11 D 41.5 3.64 31.1 1.18 A
LEGEND *Confirmatory
age effect
**Confirmatory
age effect
New genes
for stroke
Aged-specific
3 days
Aged-specific
14 days
Young-specific,
3 days
Young-specific,
14 days
There were several distinct patterns of gene regulation: persistently upregulated (A), transiently upregulated, (B), “late-upregulated” (C), or “late-downregulated” (D).
Aged animals showed larger numbers of genes that were late-upregulated (type C). The young rats, in contrast, had a much larger number of transiently upregulated
(type B). Note that this representation does not take into account the fold changes for individual genes but the relative change in gene expression at days 3 and
14 post-stroke. FC, fold change; SD, standard deviation; EP, expression pattern; NC, no change; TF, transcription factor; EC, endothelial cell; BV, blood vessel; VSMC,
vascular smooth muscle cell; PVC, perivascular cells; BL, basal lamina; ECM, extracellular matrix.
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a collagenase secreted by fibroblasts in the infarcted area of aged
rats at 2 weeks post-stroke. We also noted the downregulation of
Bai2, a brain-specific, de novo angiogenesis inhibitor (Table 2).
POST-STROKE SPROUTING ANGIOGENESIS IS DELAYED IN AGED
BRAINS
Hypoxia is a potent stimulator of angiogenesis. Among “new-for-
stroke,” pro-angiogenic transcription factors, we noted the con-
stant and robust upregulation (fourfold to sixfold) of hematopoi-
etically expressed homeobox (Hhex), runt-related transcription
factor 1 (Runx1), and the SRY-box containing gene 7 (Sox7 ), all of
them previously unknown to stroke models.
Tissue hypoxia activates Vegfa and Vegfc expression as well
as the expression of other transcripts encoding angiogenic fac-
tors such as angiopoietin-2 (Angpt2) and the “new-for-stroke,”
angiopoietin-like 2 (Angptl2), angiopoietin-like 4 (Angptl4), and
the endothelial and SMC chemoattractant Cxcl1 and its receptor
Cxcr2, on EC. We noted the mirrored expression of Angpt2 and
Angptl4, those expression decreased with time in young rats but
increased by day 14 in the brains of aged rats (Table 2).
Vascular endothelial growth factor-A and its receptorsVEGFR1,
VEGFR2, and neuropilins (NRP1, NRP2) play critical roles in
angiogenesis. Of note was the specific and delayed upregulation
(5.7-fold) of Nrp1 mRNA in the peri-infarcted area of aged rats.
VEGFR2-induced migration of EC is modulated by several
genes including calcium and integrin-binding 1 (calmyrin)(Cib1),
collagen, type VIII, alpha 1 (Col8a1), endoglin (CD105)(Eng ),
fibulin-5 (Fbln5), integrin, alpha 5 (fibronectin receptor) (Itga5),
lymphoid enhancer-binding factor 1 (Lef1), platelet/EC adhesion
molecule 1 (Pecam1), pituitary tumor-transforming 1 interact-
ing protein (Pttg1ip), S100 calcium-binding protein A4 (S100a4),
SH2B adaptor protein 3 (Sh2b3), tropomyosin 3, gamma (Tpm3),
tropomyosin 4 (Tpm4). Except for Fbln and Sh2b3, all other tran-
scripts showed delayed upregulation to various levels (threefold
to eightfold) in the brains of aged rats. Most of them, except Eng
and Pecam1, have not been previously described in stroke models
or human cases. Of note was the consistently higher expression of
Plod2 and S100a4 mRNAs, two markers of proliferating fibroblasts
(Basile et al., 2011) in young animals (Table 2).
The proliferation of vascular SMCs, the second major cell
type involved in post-stroke angiogenesis, was modulated by sev-
eral “new-for-stroke” genes including the pro-angiogenic factors
lymphoid enhancer-binding factor 1 (Lef1), transgelin (Tagln),
wingless-type MMTV integration site family, member 4 (Wnt4a)
but also by the well-known matrix metallopeptidase 2 (Mmp2). In
addition, Lef1 and Wtn4a expression showed a strong age effect,
being increased in young animals only. In contrast, in aged animals
Lef1 and Wtn4 transcripts were increased with delay by twofold to
threefold over the levels in young animals. Similarly, Vegfa and
Vegfc mRNAs were increased at day 14 after stroke only in young
animals albeit at moderate levels (about twofold) (Table 2).
Hypoxia-induced vessel dilation leads to the release of per-
icytes, SMCs, and fibroblasts. During the activation phase of
angiogenesis, ECs and fibroblasts migrate into extracellular space,
proliferate, and release cytokines and angiogenic chemokines like
CXCL1, CXCL12/CXCR4, and VEGF, which in turn activate cir-
culating EPCs, which eventually integrate into tube structures and
differentiate into mature EC that become incorporated into the
newly formed blood vessels (Kanzler et al., 2013). The high Cxcl1
mRNA levels in young but not aged rats at day 3 post-stroke
suggest that the recruitment of EPCs may be more efficient in
young animals. CXCL12 and its receptor CXC chemokine recep-
tor 4 (CXCR4), which are expressed at high levels in both vascular
and hematopoietic progenitor cells, play a critical role in the devel-
opment of the heart and blood vessels, as well as in the regulation
of motility and differentiation in EPC via the Rho GTPase, Rac2
(Shen et al., 2012) (Table 2).
RECONSTRUCTION OF A NEW BASAL LAMINA AND ECM OCCURS
EARLIER IN YOUNG BRAINS
During the resolution phase, migration and proliferation of ECs
is stopped, and at this step ECs reconstitute their BL. Except
for Col6a3 mRNA, which showed constant high levels in both
age groups, the expression of collagen type IV, alpha 2 (Col4a2),
fibronectin 1 (Fn1), laminin gamma 1 (Lamc1), nidogen 2 (Nid2),
and podoplanin 3 (Plod 3) mRNAs was higher in the brains of
young animals at day 3 post-stroke as compared to aged ani-
mals, strongly suggesting that BL and extracellular matrix (ECM)
reconstruction occurs earlier in young animals. Nidogen 2 is a
ubiquitous component of blood vessel BL. The nidogen–laminin
γ1 interaction plays a key role in BL assembly (Mokkapati et al.,
2011). New genes to be considered for vascular restoration after
stroke included Col6a3, Fn1, and Lamc1 (Table 2).
DISORGANIZED TUBE FORMATION AND MATURATION IN AGED RAT
BRAINS
Subsequent to EC and EPC proliferation, the new cells reorganize
into three-dimensionally capillary-like tubular structures. Under
hypoxic conditions, ANG-2 promotes the dissociation of pericytes
from pre-existing vessels and primes the vasculature for an angio-
genic response by increasing vascular permeability to proteases,
inflammatory cytokines, or angiogenic myeloid cells (Hammes
et al., 2004). During BV maturation, ANGPT2–TIE2 induces EC
apoptosis and participates, along with VEGF-C in lymphatic pat-
terning. ForAngpt2 mRNA, we noted a mirrored expression in the
two age groups: the Angpt2 mRNA decreased from day 3 to day 14
in the young rats but then increased during the same time period
in aged rats.
Vascular maturation also involves endothelial cell apoptosis.
Pro-apoptotic factors and inducers of apoptosis in EC included
the tumor necrosis factor, member 10 (Tnfsf10) mRNA, which
showed very high levels by day 14 in aged rats as compared to
young rats, highly suggestive of a premature depletion of ECs
that are needed for vascular reconstruction (Chiang et al., 2013).
Likewise, we noted the low expression levels for the runt-related
transcription factor 3 (Runx3) mRNA, a negative regulator of EPC
proliferation, especially in aged animals.
Quiescent ECs are covered by pericytes that secrete ANG-1,
which contributes to vessel stabilization by facilitating EC–ECM
and EC–mural cell interactions. Hypoxia, VEGF-A, and PDGF-B
have been reported to elevate ANG-1 expression in perivascu-
lar cells such as pericytes or SMCs (Park et al., 2003). A delayed
upregulation in the brains of aged rats was also recorded for
angiopoietin-1 (Angp1) mRNA, mainly expressed in perivascular
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cells (pericytes), collagen type III (Col3a1) mRNA, a component
of adventitia secreted by fibroblasts, and Tnfsf10 transcripts.
A timely expression in both age groups was noted for col-
lagen type I (Col1a2) mRNA, a component of the adventitia
secreted by fibroblasts, integrin beta 4 (Itgb4), fibronectin type III
domain containing 1 (Fndc1), the pro-angiogenic Notch2, procol-
lagen C-endopeptidase enhancer (Pcolce), serine carboxypeptidase
1 (Scpep1), and Tie1 mRNAs, which encodes a receptor on EC
involved in capillary maintenance by inhibiting the Angpt1/Tie
signaling pathway (Yuan et al., 2007).
An untimely expression was seen for insulin-like growth factor
binding protein 7 (Igfbp7 ) and Glypican-3 (Gpc3) mRNAs. Gpc3
encodes the co-receptor for fibroblast growth factor-9 (FGF9)
and a loss of glypican-3 function causes growth factor-dependent
defects in cardiac and coronary vascular development (Ng et al.,
2009). Both transcripts were robustly increased (fourfold to six-
fold) by day 14 in aged animals, suggesting that angiogenesis was
just being initiated at this timepoint rather than entering the
resolution phase, as was the case in young rats (Table 2).
BLOOD VESSEL STABILIZATION AND FIBROSIS
Genes contributing to BV stabilization were numerous. Of these,
we noted the timely and highly expressed (fourfold to eight-
fold) cysteine-rich (osteonectin) (SPARC), especially in aged rats
(twofold over young animals).
However, excessive synthesis of ECM and BL components may
lead to fibrosis, a process that is greatly augmented by the pres-
ence of myofibroblasts in the inflammatory milieu of post-stroke
aged animals. Likewise, an inhibition of metalloproteinases may
have the same fibrogenic effect by allowing the accumulation of
ECM components. Tissue inhibitor of metalloproteases (Timp1),
which encodes a natural inhibitor of matrix proteases, was greatly
increased (31-fold) by day 14 in aged but not young rats. Likewise,
interleukin 13 receptor, alpha 1 (Il13ra1) gene encoding a recep-
tor on SMCs and fibroblasts and which is also a new player for
stroke scholars, may promote fibrosis by inhibiting metallopro-
tease activity in fibroblasts (Bailey et al., 2012). Metalloproteases
such as MMP2 also contribute to fibrosis directly as modulators of
the conversion of fibroblasts to myofibroblasts, especially in aged
rats. Indeed, Mmp2 expression was greatly increased by day 14 in
aged rats (sevenfold over the young rats).
Post-stroke inflammation is a major factor that augments the
fibrosis. During the resolution phase at day 14, we noted a large
increase in the expression of inflammation-related genes required
for fibrosis in aged rat brains. The inflamed endothelium expresses
large amounts of transcripts (sixfold over the young rats), encod-
ing the angiogenic stromal cell-derived factor-1a CXCL12, a
chemoattractant for EPCs and SMCs. Activated EPCs upregulate
gene expression for chemokine receptors, Cxcr2 and Cxcr4, the
principal receptors for CXCL1 and CXCL12, respectively (Kanzler
et al., 2013).
Macrophages are a critical factor in the initiation of fibrosis
through the production of TNF,TGFβ, IL-18, and of PDGF (Wynn,
2008). Macrophage expressed 1 (Mpeg1) mRNA showed large and
persistent increase in both age groups. Along this line of evidence,
IL-18 after stroke is produced by microglia and contributes to
fibrosis in the aged rat brain via STAT3 activation, leading to a large
accumulation (237-fold over controls) of collagen III (Col3a1)
transcripts that are normally expressed in adventitial fibroblasts
(Matsui et al., 2013) (Table 2).
TGF-beta signaling is the second major fibrogenic pathway in
the post-stroke brain.Tgfb1 andTgfbr2 mRNAs showed extremely
high levels (10- to 57-fold over controls) at day 14 in post-stroke
rats. Tgfbi, which is new-for-stroke research, was, to the contrary,
specifically increased in young animals early after stroke and recov-
ered by day 14 post-stroke. Aged animals failed to upregulateTgfbi
transcripts. However, other components of the TGF-beta signaling
such as TGF beta, encoding receptor I (Tgfbr1) did not show an
age-dependency.
TGF-beta signaling together with PDGF induces the prolifera-
tion of myofibroblasts, which secrete collagen type I (COL1a1),
collagen triple helix repeat containing 1 (CTHR1) and pro-
lyl 4-hydroxylase, beta polypeptide (P4Hb), those mRNAs were
increased with delay at day 14 in the brains of aged animals. In
particular, we noted the high Cthrc1 transcript levels specifically
in the aged animals (sixfold over the young animals). CTHRC1
is expressed by injured arteries, where it is induced abundantly in
adventitial fibroblasts and neointimal SMCs and may inhibit SMC
proliferation via the Tgf β pathway (LeClair et al., 2007). However,
both Pdgfra and Pdgfrb transcripts encoding the PDGF recep-
tors on pericytes, had a regular expression time course in both
age groups. Of note was the expression of Wnt5a, which showed
consistently increased levels only in aged animals (Table 2).
Post-stroke angiogenesis resembles in many ways the angio-
genesis in tumors, i.e., the newly formed vessels are leaky via the
Il6r/Il6st/STAT1/3 pathway. IL-6 is synthesized by myeloid cells,
fibroblasts, and ECs and the binding to its receptor (IL6R) that trig-
gers gp130-mediated activation of STAT1 and STAT3, was found
to be involved in vascular leakage (Wei et al., 2013). Stat1 and Stat2
are new players in the stroke search for novel therapeutic targets.
Of note, Stat2 expression was increased by day 14 only in the aged
animals.
HISTOLOGY
The development of the infarct core was visualized by immunohis-
tochemistry for NeuN, a sensitive indicator of neuronal viability.
As previously reported for this model (Popa-Wagner et al., 2007b),
the development of the infarct was more rapid in aged rats, but
by day 14, the cortical infarcts were similar in size in both age
groups, i.e., 35± 3.1% of total cortical volume in young rats and
40± 7.9% in aged rats (Figures 2A,B).
ANGIOGENESIS ASSESSMENT BY IMMUNOFLUORESCENCE
CD31 (PECAM-1) antigen is expressed on ECs and pericytes, and
is considered a marker of post-stroke angiogenesis (Deddens et al.,
2013). In the unlesioned hemisphere, blood vessels were rarely
detected by CD31 immunofluorescence (Figure 2C). By day 14
after stroke, new blood vessels were emerging in the per-infarcted
area of young animals (Figure 2D). The revascularization process
in aged animals was delayed and was characterized by the accumu-
lation of CD31-immunopositivity in the fibrotic scar (Figure 2E).
Beyond the fibrotic scar, however, in a region that we dubbed “islet
of regeneration,” vigorous angiogenesis was detected in aged ani-
mals as well (Figure 2F). By day 14, mature BV had developed in
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FIGURE 2 | Infarct size and angiogenesis assessment by
immunofluorescence. (A,B) By NeuN immunohistochemistry, the cortical
infarcts were similar in size in both age groups, i.e., 35±3.1% of total cortical
volume in young rats and 40±7.9% in aged rats. (C) In the unlesioned
hemisphere, CD31-positive blood vessels (green) were rarely detected. (D) By
day 14, new blood vessels were emerging in the peri-infarcted area of young
animals. The revascularization process in aged animals was delayed and was
characterized by the accumulation of CD31-immunopositivity in the fibrotic
scar (E). Beyond the fibrotic scar, however, in a region that we dubbed “islet
of regeneration,” vigorous angiogenesis was detected in aged animals as well
(F). By day 14, mature BV had developed in the peri-infarcted area of young
animals (G). Similarly, new, mature blood vessels were detected in the same
areas of the aged rats (I). Please note the unexpected expression of CD31 in
the wall of the subventricular zone both in young (H) and aged animals (J).
(C–J) are Z -projection images. BV, blood vessel; IC, infarct core; IR, islet of
regeneration; PI, peri-infarct; Sc, scar; SVZ, subventricular zone.
the peri-infarcted area of young animals (Figure 2G). Similarly,
new, mature blood vessels were detected in the same areas of the
aged rats (Figure 2I). Quite interestingly, we report the unexpected
expression of CD31 in the wall of the subventricular zone (SVZ)
both in young (Figure 2H) and aged animals (Figure 2J).
FIBROBLASTS MAY CONTRIBUTE TO THE FIBROTIC SCAR
Under hypoxic conditions, the newly generated fibroblasts express
prolyl 4-hydroxylase (P4Hbeta), a member of the non-heme iron
(II), α-ketoglutarate-dependent dioxygenase family, which cat-
alyzes hydroxylation of proline residues in the collagen strands.
The fibroblasts/fibrocytes emanate from the CD31-positive vas-
cular wall, a process that was more evident in young brains
(Figure 3A). However, in the aged animals we noted a preferen-
tial agglomeration/accumulation of fibroblasts in the scar region
(Figure 3B). Double labeling of cells with a P4Hbeta antibody
(green) and a proliferation marker (BrdU, blue) in aged rat brains
revealed that some proliferating fibrocytes/fibroblasts had BrdU-
positive nuclei in the peri-lesional area (arrowheads). Eventually,
some co-labeled cells emanate from the capillary wall (Figure 3C,
inset, arrowheads). Quantitatively, at day 14 post-stroke the vascu-
lar density was higher in the peri-infarcted area of young animals
as compared to the similar region of aged rats (twofold). However,
beyond the inhibitory fibrotic scar, in a region made of soft tissue
that we dubbed “islet of regeneration,” the vascular density was
similar in the two age groups (Figure 3D).
SEMI-QUANTITATIVE ANALYSIS OF ANGIOGENESIS IN THE RAT MODEL
By dot blot (Figures 4A,B) and ELISA analysis, CD31 immunore-
activity in homogenates of the peri-infarcted cortex was slightly
increased from day 3 to day 14 in both age groups (Figure 4A).
However, by ELISA, the CD31 levels in young animals were
much higher than those of aged animals both at day 3 (fourfold;
p= 0.001) and day 14 (threefold; p= 0.001) (Figure 4C).
ANGIOGENESIS IN POST-STROKE HUMAN TISSUE
In control subjects, CD105 immunoreactivity was detected in the
endothelial lining of the cortical capillaries in an orderly pattern
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FIGURE 3 | Double immunofluorescence prolyl 4-hydroxylase/CD31
and prolyl 4-hydroxylase/BrdU in the peri-infarcted area. (A) Double
labeling of cells with a P4Hbeta antibody (green) and CD31 (red) revealed
that under hypoxic conditions P4Hb-positive fibroblasts/fibrocytes seems
to emanate from the vascular wall (inset, arrowheads) a process that was
more evident in young brains. (B) In the aged animals, we noted a
preferential agglomeration/accumulation of fibroblasts in the scar region.
(C) Double labeling of cells with a P4Hb (green) and the proliferation
marker BrdU (blue) in aged rat brains revealed that some proliferating
fibrocytes/fibroblasts had BrdU-positive nuclei in the peri-lesional area
(arrowheads). Eventually, some co-labeled cells emanated from the
capillary wall [(C), inset, arrowheads]. (D) At day 14 post-stroke, the
vascular density was higher in the peri-infarcted area of young animals as
compared to the similar region of aged rats (twofold). However, beyond
the inhibitory fibrotic scar, the vascular density was similar in the two age
groups. (A–C) represent Z -projection images.
(Figures 5A,B). In the peri-infarcted area, CD105 immunostain-
ing was present in an angiogenic complex consisting of numerous
tortuous, branched blood vessels of various lengths including ran-
domly scattered ECs (Figure 5C). In the infarct core, CD105
immunopositivity was present in the endothelium of spared blood
vessels (Figure 5D). The angiogenic process was mostly evident in
the peri-infarcted area, which showed the highest vascular den-
sity as compared to the contralateral side and the control group
(Figure 5E). We also noted a strong correlation between post-
stroke angiogenesis and post-stroke survival time [r(13)= 0.984,
p< 0.001] (Figure 5F).
PATTERNS OF GENE EXPRESSION AFTER STROKE IN ANIMAL MODEL
The kinetics of gene expression over a longer time period gives us
clues as to what processes in the long run could be defective at
the level of transcription in aged rodents. We distinguished two
patterns of gene regulation, as depicted schematically in Figure 6
and shown in detail in Table 2: transiently upregulated (type B,
expression recovered after the acute phase) and “late-upregulated”
(type C, expression went up after the acute phase).
A comparison of the global pattern of gene expression indi-
cated that aged animals showed a larger numbers of genes that
were belatedly upregulated (orange line) than the young animals.
The young rats, in contrast, had a larger number of transiently
upregulated genes (green line) (Figure 6, Table 2).
DISCUSSION
Stroke induces a specific remodeling of the brain vasculature.
Using an aged rat model of stroke, we found that at 2 weeks
after stroke the microvascular density was reduced in aged rats
as compared to young animals on a background of persistent
upregulation of genes coding for matrix proteases and inflamma-
tory mediators. However, beyond the inhibitory fibrotic scar, in a
region made of soft tissue that we dubbed “islet of regeneration,”
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FIGURE 4 | Quantitative analysis of CD31 expression in the rat model.
By dot blot (A) and ELISA analysis (C), CD31 immunoreactivity in the
peri-infarcted area was slightly increased from day 3 to day 14 in both age
groups. However, CD31 levels in the young animals were clearly higher
than those in aged animals both at day 3 (fourfold; p=0.001) and day 14
(threefold; p=0.001) both by dot blot (B) and ELISA (C).
the vascular density was similar in the two age groups. Unlike in
rats, the post-stroke angiogenesis in human patients is vigorous at
1 week post-stroke, and correlates well with the post-stroke sur-
vival time. By comparative transcriptomics of angiogenesis, we
identified 36 new stroke-related genes some of which may be used
as new therapeutic targets that may help redress the dysregula-
tion of angiogenesis in the infarcted area of aged brain. We also
found that the aged human brain is capable of mounting a vigor-
ous angiogenic response after stroke, which most likely reflects the
remaining brain plasticity of the aged brain.
SPROUTING ANGIOGENESIS IS IMPAIRED IN AGED RATS
Angiogenesis has multiple beneficial roles in the post-ischemic
brain, contributing to (i) the stabilization of brain hemodynam-
ics, thus preventing subsequent stroke events, (ii) the prevention of
neuronal degeneration via release of neurotrophic growth factors,
(iii) the removal of dead cells from the tissue by blood-derived
macrophages that find access to the ischemic lesion, and (iv)
the attraction of neural precursor cells that again release growth
factors (Slevin et al., 2006; Hermann and Zechariah, 2009).
Although infarct development was more rapid in aged rats by
day 14, the cortical infarcts were similar in size in both age groups
(Popa-Wagner et al., 2007a). Unlike infarct size, sprouting angio-
genesis was delayed in aged animals. The young animals had higher
levels of CD31 and a significantly increased vascular density. The
disorganized and delayed vascular tube formation in aged rats cor-
responded to a divergent pattern of gene expression by day 14 in
the infarcted aged brains as compared to the young animals. A
similar divergent pattern of gene expression has been reported by
our group for genes involved in CNS physiology and homeosta-
sis, or for genes required for embryonic development and CNS
remodeling after stroke (Buga et al., 2012).
Automatic assignment of genes to specific processes is a valu-
able technique, but may nevertheless lead to spurious functional
associations. It is thus important to supplement these methods
with one-by-one gene function searches in the context of the
pathophysiology of stroke. Because young rats recover behav-
iorally within 2 weeks after stroke (Buchhold et al., 2007), in this
Section “Discussion” we assume that the gene expression related
to angiogenesis is optimal in the young animals. The transcrip-
tomic analysis strongly suggests that the persistent upregulation
of several genes involved in matrix degradation and inflammation
is mainly responsible for the delayed angiogenesis in the infarcted
area of aged rats. In response to prolonged hypoxia, fibroblasts
degrade type I collagen, one of the major extracellular proteins of
the vasculature, and the available evidence suggests that type I col-
lagenolysis is mediated by secreted as well as membrane-anchored
members of the matrix metalloproteinase (MMP) gene family,
including Mmp8, Mmp12, and Mmp14 (Sabeh et al., 2009; Liu
et al., 2010). In young animals, the MMPs are strongly upregulated
early after stroke, but then decrease or remain at the same level by
day 14 post-stroke. In aged animals, in contrast, Mmp8, Mmp12,
andMmp14 were increased by day 14. Similar increases were noted
for macrophage marker Mpeg1 and monocyte recruitment factor,
Tnfrsf1a and Tnfrsf1b transcripts.
Matrix metalloproteinases are responsible for the breakdown
of the ECM under hypoxic conditions. During the recovery phase,
however, MMP14 could play an important pro-angiogenic role
and promote tissue recovery after stroke. Indeed, impaired angio-
genesis has been also observed in Mmp14 null mice (Shimokawa,
2008). Nonetheless, persistent overexpression of MMPs might lead
to inefficient angiogenesis and tissue repair after stroke (Danielsen
et al., 2011). Hyperactivation of MMP14 has been associated
with increased leakiness and an immature blood vessel phenotype
(Sounni et al., 2010), but also with formation of fibrous tissue
by promoting collagen invasion in vascular SMCs (Mountain
et al., 2012). Likewise, in the latest stage after ischemia, MMP14
is responsible for chemokine activation, in particular TGF-beta
pathway via ALK5/Smad3 (Sounni et al., 2010), which can affect
the stability of blood vessels.
In previous work, we described the fulminant development of
inflammation in the infarcted area of aged rats (Badan et al., 2003).
Prolonged hypoxia induces blood vessel dilation, detachment of
pericytes, and EC sprouting. When vessels lose pericytes, they
become hemorrhagic and hyperdilated, which leads to edema (the
main cause of death in the first 3 days post-stroke) and facilitates
the infiltration of immune cells into the lesioned area.
TNF-alpha is a potent neuromodulator with multiple effector
functions, and has been strongly implicated in the recruitment
of leukocytes and monocytes after injuries both centrally and
in the periphery via TNFR1, which is encoded by the Tnfrsf1a
and Tnfrsf1b genes. TNF receptors are expressed on many cell
types including ECs of fibrovascular tissue (Majka et al., 2002),
and promote inflammation through activation of cytokines and
MMPs (Bradley, 2008; D’Mello et al., 2009; Jasielska et al., 2010).
Many of the pro-inflammatory responses of TNF in vivo can be
traced to its effects on the vascular endothelium and leukocyte and
monocyte infiltration. TNF induces the expression of endothelial
adhesion molecules that support leukocyte–endothelial interac-
tions and stimulates the local production of chemokines like
CCLl2 and CXCL10, which promote leukocyte activation and
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FIGURE 5 | Angiogenesis in post-stroke human tissue. (A) In control
subjects, CD105 immunoreactivity (red) was present in the endothelial lining
of the cortical capillaries in an orderly pattern. Neuronal nuclei are shown in
brown. An enlarged view is shown in (B). (C) In the peri-infarcted area, CD105
immunostaining was present in tortuous, branched blood vessels including
randomly scattered ECs. (D) In the infarct core, CD105 immunopositivity was
present in the endothelium of spared blood vessels. (E) Quantitatively, the
highest vascular density (given as number of microvessels/0.7386 mm2) was
in the peri-infarcted area as compared to the contralateral side and the control
group. (F) We also noted a strong correlation between post-stroke
angiogenesis and post-stroke survival time [r (13)=0.984, p<0.001]. CX,
cortex; PI, peri-infarct; IC, infarct core. Bars, 50µm.
transmigration into tissue (Bradley, 2008). Our results indicate
that Tnfrsf1a and Tnfrsf1b mRNAs are robustly upregulated in the
early stage of ischemic damage in both age groups, but its expres-
sion was robustly increased by day 14 post-stroke in the aged brains
only. Recent studies with Tnfrsf1a−/− and Tnfrsf1b−/− mice have
shown that Tnfrsf1b promotes the recruitment of inflammatory
cells to the site of injury and exacerbated pathologic angiogenesis,
whereas Tnfrsf1a was required for apoptosis, suggesting persistent
inflammation and apoptotic events in the aged brains.
A sustained expression of the pro-inflammatory TNF is
also responsible for prolonged upregulation of CXCL12–CXCR4
chemokine ligand–receptor axis on infiltrating leukocytes in the
aged brains (Wang et al., 2012). Soon after stroke Cxcl12 expres-
sion promotes EPC recruitment at the injury site, but later on it
becomes a powerful chemoattractant for SMCs that may further
contribute to the formation of the fibrotic scar (see below).
ANGIOGENESIS IS INCREASED AT 2,WEEKS POST-STROKE IN YOUNG
VS. AGED RATS
Following stroke, angiogenesis, which is defined as formation of
microvessels from existing microvessels, is enhanced in the per-
infarcted region as compared to the contralateral unlesioned cor-
tex (Wang et al., 2005; Kilic et al., 2006; Zechariah et al., 2013). By
CD31 immunohistochemistry and ELISA assay, the concentration
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FIGURE 6 | Patterns of gene expression after stroke in animal model. We
distinguished two patterns of gene regulation, transiently upregulated (type
B, expression recovered after the acute phase, green line) and
“late-upregulated” (type C, expression went up after the acute phase; orange
line). Please note that aged animals showed larger numbers of genes that
were belatedly upregulated than the young animals. The young rats, in
contrast, had a larger number of transiently upregulated including Cxcl1,
S100a4, Runx3, Tgfbi, Vegfa, Vegfc.
of CD31 and the density of newly formed blood vessels were signif-
icantly higher at day 14 in the brains of post-stroke young animals.
Increased angiogenesis in post-stroke young animals was presum-
ably due to increased sprouting angiogenesis. Remarkable was
the delayed angiogenic response on a background of a fulminant
inflammatory reaction in the aged, injured brains.
Angiogenesis in young animals benefited from the early, vigor-
ous expression of the angiogenic factors Angpt2,Angptl2,Angptl4,
andPecam (CD31) in EC (Le Jan et al., 2003; Tazume et al., 2012) as
well as an increased expression of Cxcl1 mRNA in ECs. The angio-
genic chemokine CXCL1 is a secreted growth factor that interacts
with the G-protein-coupled receptor CCR2 on ECs (Miyake et al.,
2013). ANGPTL2 induces sprouting in ECs through an autocrine
or paracrine action and therefore is a potent stimulator of angio-
genesis (Kim et al., 1999). Likewise, the young rats benefited from
the early upregulation of genes required for endothelial cell prolif-
eration and migration, including Cib1 and Lef1 mRNAs. CIB1 is a
calcium and integrin-binding protein-1 that is essential for proper
EC signaling and function such as migration, proliferation, and
nascent tubule formation, and therefore is critical in ischemia-
induced angiogenesis in the retina, as well as ischemia-induced
adaptive angiogenesis (Zayed et al., 2007).
Sprouting angiogenesis was delayed in injured, aged rat brains.
In particular, we noted the mirrored expression of Angptl4, Cib1
and Col8a1, Eng, Lef1, Nrp1, Pecam, Tpm4 transcripts, suggesting
that delayed cellular proliferation in conjunction with a delayed
secretion of proper migrating substrates is the main cause of
delayed sprouting angiogenesis in the aged rat brains after stroke.
The normal vessel wall ECM is composed predominantly of type I
and III collagens, elastin, and proteoglycans, with smaller amounts
of fibronectin, laminins, and type IV collagen.
Regarding with signaling pathways, those expressed during
embryogenesis such as FGF/FGFR, Notch, Shh, or Wnt7a/7b are
not activated during post-stroke angiogenesis suggesting that post-
stroke angiogenesis is not simply a recapitulation of developmental
angiogenesis. One of the few activated signaling pathways was
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Wnt4. In response to arterial injury, SMCs shift from a quies-
cent, contractile phenotype to a proliferative, synthetic state. In
this phenotypic transition, Wnt4a and Lef1 act in concert to pro-
mote endothelial cell proliferation. Lymphoid enhancer-binding
factor 1 (Lef1) is a member of the Lef/Tcf transcriptional regu-
lator family that mediates beta-catenin-dependent transcription
in the Wnt-beta-catenin pathway and promotes endothelial cell
migration (Planutiene et al., 2011). Aged animals failed to initi-
ate the expression of this EC migration pathway and displayed
abnormally high levels of Wnt4a mRNA by day 14 post-stroke.
TIMELY BASAL LAMINA RECONSTRUCTION AND TUBE FORMATION IN
YOUNG BRAINS
During the activation phase of angiogenesis, ECs and fibrob-
lasts start to degrade their vascular BL, migrate into extracellular
spaces, proliferate, and form vascular tubes. Delayed and persis-
tent expression of the matrix-degrading proteasesAdam17 mRNA
in aged brains may have delayed the reconstruction of BL in aged
animals. Laminin gamma1 (Lamc1),Nid2, and Plod2 mRNAs were
increased exclusively in young animals in the early stage after cere-
bral ischemia, suggesting that these genes play an essential role in
post-stroke angiogenesis. NID2 and LAMC1 are components of
the BL and promote ECM interaction and cell adhesion. Likewise,
PLOD2 is expressed in fibroblasts and is required for tube for-
mation and ECM stiffening and collagen fiber alignment (Gilkes
et al., 2013).
Angpt1/Tie2 signaling is mainly responsible for capillary main-
tenance. Targeted Tie1 disruption results in embryonic lethality
due to edema, hemorrhage, and microvessel rupture, a finding that
suggests that Tie 1 is required for vascular integrity (Yuan et al.,
2007). An increased expression of Angpt2, Col4a2, Runx3, S1004,
Vegfa,Vegfc, and Tie2 mRNAs in the angiogenic area of young rats
may have been also essential in promoting timely angiogenesis as
compared to aged animals. Vegfa and Vegfc mRNAs were specifi-
cally increased by day 14 after stroke in young animals, and thus
may have contributed to a sustained angiogenic response. This
hypothesis is strongly supported by the mirrored expression of
Col4a2, Lamc1, and Tie2 in the angiogenic area of aged animals.
An increased collagen IV alpha2 level can act as negative reg-
ulator of angiogenesis in the latest stage after stroke by inhibit-
ing angiogenesis via an integrin-mediated apoptotic mechanism
(Kozulin et al., 2010). Collagen, type IV, alpha 2 (COL4A2) is
an abundant component of BL of the cerebral vasculature and
Col4a2 mutations cause small-vessel disease and hemorrhagic
stroke (Gould et al., 2006; Jeanne et al., 2012). Runx3 was one of
the very few transcripts showing high levels at 2 weeks post-stroke
in young rats. Runt-related transcription factor 3 (Runx3) is essen-
tial for normal development and may be required for maturation
of newly formed blood vessels (Lee et al., 2013).
Vessel stabilization can be achieved by the upregulation of
Pdgfrb, S100a4, Scpep1, and SPARC genes, which promote the
recruitment of pericytes and SMCs on the emerging blood
vessels. Fibroblast-derived proteins increase the stiffness of the
matrix. One of those proteins, S100a4 (also called fibroblast-
specific protein) promotes sprouting and lumen formation in
three-dimensions. Our studies also suggest that the new “stroke
genes” Fnbl5, Fndc1, Pcolce, Scpep1, and Igfbp7 induce EC-lumen
formation (Newman et al., 2011) by increasing the stiffness of the
ECM and increasing BV elasticity (Pshezhetsky and Hinek, 2009).
FBLN5 (fibulin-5) is an extracellular matrix calcium-binding gly-
coprotein expressed in elastic fiber-rich tissues that is necessary
for elastogenesis (Yanagisawa et al., 2009; Noda et al., 2013).
Tie2 gene deletion causes embryonic death with endocardial
defects, hemorrhaging, and impaired vascular network formation
suggesting that Tie2 is primarily required for spouting angiogen-
esis and then for capillary maintenance (Puri et al., 1995; Patan,
1998). Tube formation and BV maturation was clearly delayed in
the damaged area of aged animals and was due to the delayed
upregulation of several key genes, including Angpt1,Angpt2,Gpc3,
Igfbp7, SPARC, and Tie2.
We noted the unusually high levels of the pro-apoptotic gene
Tnfsf10 at day 14 in the peri-lesional area of aged brains, suggest-
ing that the lower vascular density in the aged rat brains may be
due to an increased apoptosis of EC.
THE BUILDUP OF FIBROTIC TISSUE WAS PROMINENT IN THE SCAR
REGION OF AGED RATS
Persistent inflammation, excessive synthesis of the components of
the BL as well as inhibition of matrix proteases may limit the plas-
ticity and remodeling of blood vessels and favor the accumulation
of fibrotic tissue in the scarring region after lesioning (Johnson and
Dipietro, 2013). This phenomenon was exaggerated in aged rats
by an increased expression of several new “stroke genes,” including
Il13a, Rassf4, Tgfbi, and Wnt5b, in the peri-lesional cortex of aged
rats only.
Following cardiac ischemia, it is currently thought that fibrob-
lasts migrate to the infarcted region and, under the influence of
TGF-beta, differentiate into a myofibroblast phenotype character-
ized by smooth muscle a-actin expression (Willems et al., 1994;
Sun et al., 2000; Frangogiannis et al., 2002; Virag and Murry, 2003;
Squires et al., 2005; Wynn, 2008). Our study suggests that a sim-
ilar scenario may also hold for central nervous tissue. We found
that P4hb-expressing fibroblasts displayed a preferential accumu-
lation in the scar region of post-stroke aged brains, and may have
contributed to the formation of the fibrotic scar via TGF-beta sig-
naling. The source of migrating fibrocytes/fibroblasts appears to
be the vascular wall itself, a phenomenon that we described for
migrating pericytes after stroke in aged rats (Popa-Wagner et al.,
2007b).
Previous studies have shown that TGF-beta-induced pheno-
typic switch of adventitial fibroblasts into hybrid non-muscle-
SMC known as myofibroblasts is mediated by the MMP2/Timp1
pathway and occurs during wound healing and various fibrotic
disorders (Short et al., 2004; Misra et al., 2010). During tissue
healing, the primary role of scar myofibroblasts involves the syn-
thesis and deposition of collagen α(1) type 1 and smooth muscle
α-actin (El-Helou et al., 2012). Indeed, we noted extraordinarily
high levels of Col1a1, Mmp2, and Timp1 transcripts by day 14 in
the peri-lesional area of the aged brains.
THE NEWLY FORMED BLOOD VESSELS MAY BE LEAKY
Aberrant angiogenesis is a major contributor to tumor growth.
There are parallels between the structure of post-stroke angiogen-
esis and cancer vasculature with regard to blood vessel immaturity
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and vascular permeability. An increased expression of the newly
identified stroke genes Il6ra, Il6st, S100a4, Stat1, and Stat2, but also
the known genes Col1a1, Col1a2, Col3a1, has been implicated in
blood vessel remodeling and contributes to vascular rarefaction,
leakage, and intracranial aneurysms (Peters et al., 2001; Basile et al.,
2011).
In human aging brains, one of the most important changes
is represented by a decrease of the normal cerebral vascular net-
work. This may affect the ability of the aged subjects to mount
an adequate pro-angiogenic response after stroke (Petcu et al.,
2010). However, our findings indicate that aged human brains still
have the capability to mount a vigorous angiogenic response, as
measured by CD105 immunoreactivity, that correlated with the
post-stroke survival time. However, we think that this correlation
reflects the plasticity reserves of the aged brain rather than merely
the angiogenic response.
ROBUST ANGIOGENESIS BEYOND THE FIBROTIC SCAR AND THE
SUBVENTRICULAR ZONE
The anti-angiogenic nature of the fibrotic scar in aged tissue is
illustrated by the vigorous angiogenesis in the unstructured tissue
of aged rats beyond the fibrotic scar (islet of regeneration). By anal-
ogy with “scar-free” healing of embryonic tissue (Ferguson and
O’Kane, 2004), we hypothesize that the major “anti-angiogenic”
factor is the precipitous and persistent post-stroke inflammation
in the peri-infarcted area, below the fibrotic scar of the aged
animals.
Also, a robust angiogenic response was observed in the SVZ.
Angiogenesis beyond the fibrotic scar and in the SVZ has not been
studied in detail. Recently, it was reported that platelet administra-
tion after stroke increases angiogenesis in the SVZ (Hayon et al.,
2013).
CONCLUSION
We found that both age groups initiated vigorous angiogene-
sis. However, the young rats had a higher vascular density by
day 14. Key genes responsible for the increased vasculature den-
sity in young animals were Cxcl1, Lamc1, Nid, Plod2, Wnt4, and
Wnt5, mostly required for sprouting angiogenesis and BL recon-
struction. New genes for stroke also included Angptl2, Angptl4,
Mmp8, Mpeg1, and Tnfrsf1b. The vast majority of genes showed
delayed upregulated in the aged rats, presumably because of per-
sistent post-stroke inflammation. The young rats, in contrast,
had a much larger number of transiently upregulated genes.
The angiogenic response in aged rats was further diminished by
the buildup of fibrotic scar tissue. Beyond this barrier, however,
the vascular density in aged brains was similar to that of the
young animals. Similarly, we did not detect a decreased angio-
genic response to stroke in the SVZ of the aged group. We also
show that the aged human brain is still capable of mounting a
vigorous angiogenic response after stroke that reflects, most likely,
the remaining human brain plasticity (Mahncke et al., 2006; Mer-
cado, 2008). Finally, some of the newly identified stroke-related
genes may be used as new therapeutic targets that may help redress
the dysregulation of angiogenesis in the infarcted area of aged
brain.
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